The rationale of our study was thus to estimate the hospital based prevalence of p16 expression in laryngeal and pharyngeal tumors and to compare it with the p16 expression in non tumor site, for which we took tonsillar specimens after tonsillectomy in cases with recurrent acute tonsillitis. This evidence concerns the gene CDKN2A and acute tonsillitis.